This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 3 CIPO patents. Top assignee: Biohaven Therapeutics Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Gene M. Dubowchik and Patent Innovation
Introduction
Gene M. Dubowchik is an inventor associated with New Haven, Connecticut, and Biohaven Therapeutics Ltd. His patent work includes an invention concerning bifunctional degraders of galactose-deficient immunoglobulins.
Latest Patents
Dubowchik is credited with 1 patent: “Bifunctional Degraders of Galactose-Deficient Immunoglobulins.” The patent describes an approach involving compounds designed to target and degrade galactose-deficient immunoglobulins.
Career Highlights
His listed patent reflects work in therapeutic innovation and the development of approaches related to immunoglobulins. Dubowchik is associated with Biohaven Therapeutics Ltd.
Collaborations
The provided information lists Lawrence R. Marcin and Ada Vaill as coworkers. Their shared association points to a collaborative research environment connected with therapeutic development.
Conclusion
Gene M. Dubowchik’s patent activity highlights his contribution to therapeutic innovation through work on bifunctional degraders of galactose-deficient immunoglobulins.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile